Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
25
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| MCENANY PATRICK J | President and CEO | 194 | $1.02M | $52.74M | 2026-07-15 |
| Russo Gregg | Chief HR Officer | 12 | $0 | $0 | 2026-07-15 |
| Curran Daniel J. | Director | 5 | $0 | $0 | 2026-07-15 |
| Sundaram Preethi | Chief Strategy Officer | 56 | $0 | $1.30M | 2026-07-15 |
| Harper Molly | Director | 51 | $0 | $1.30M | 2026-07-15 |
| Thompson Tamar | Director | 20 | $0 | $0 | 2026-07-15 |
| Del Carmen Jeffrey | Chief Commercial Officer | 80 | $0 | $4.85M | 2026-07-15 |
| Elsbernd Brian | Chief Legal Officer | 89 | $0 | $5.69M | 2026-07-15 |
| Kalb Michael Wayne | Executive Vice President & CFO | 20 | $0 | $0 | 2026-07-15 |
| Andrews William T. | Chief Medical Officer | 10 | $0 | $0 | 2026-07-15 |
| Daly Richard J | President and CEO | 80 | $0 | $2.49M | 2026-07-15 |
| Miller Steve | Chief Operating Officer | 113 | $253.3K | $13.17M | 2026-07-15 |
| Tierney David S | Director | 99 | $27.8K | $2.98M | 2026-07-15 |
| DENKHAUS DONALD A | Director | 81 | $515.8K | $638.6K | 2026-07-15 |
| INGENITO GARY | Chief Medical Officer | 101 | $0 | $20.55M | 2025-05-14 |
| O'Keeffe Charles B | Director | 86 | $457.3K | $1.41M | 2025-02-14 |
| GRANDE ALICIA | VP, Treasurer and CFO | 99 | $20.8K | $13.21M | 2023-12-27 |
| COELHO PHILIP H | Director | 60 | $31.8K | $2.22M | 2023-05-04 |
| BRENNAN DANIEL | Chief Commercial Officer | 5 | $0 | $0 | 2019-12-02 |
| Merrigan Paul J | Chief Commercial Officer | 3 | $0 | $0 | 2015-12-30 |
| Winship M Douglas | VP, Regulatory Operations | 14 | $10.0K | $76.2K | 2015-11-04 |
| MUTH DAVID D | Exec. V.P., Corp. Development | 5 | $101.2K | $0 | 2015-05-01 |
| HUCKEL HUBERT E MD | Director | 8 | $100.0K | $0 | 2014-10-02 |
| WALLACE MILTON J | Director | 4 | $106.3K | $0 | 2012-12-12 |
| BIOMARIN PHARMACEUTICAL INC | 10% Owner | 2 | $3.75M | $0 | 2012-12-08 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| DENKHAUS DONALD A | Director | D To issuer deriv | 2026-07-15 | 2026-07-17 | 23,248 | — | $0 | 0 | SEC↗ |
| DENKHAUS DONALD A | Director | D To issuer deriv | 2026-07-15 | 2026-07-17 | 29,524 | — | $0 | 0 | SEC↗ |
| DENKHAUS DONALD A | Director | D To issuer deriv | 2026-07-15 | 2026-07-17 | 15,000 | — | $0 | 0 | SEC↗ |
| Curran Daniel J. | Director | D To issuer deriv | 2026-07-15 | 2026-07-17 | 40,000 | — | $0 | 0 | SEC↗ |
| Kalb Michael Wayne | Chief Financial Officer | D To issuer deriv | 2026-07-15 | 2026-07-17 | 39,701 | — | $0 | 0 | SEC↗ |
| Kalb Michael Wayne | Chief Financial Officer | D To issuer deriv | 2026-07-15 | 2026-07-17 | 13,788 | — | $0 | 0 | SEC↗ |
| Kalb Michael Wayne | Chief Financial Officer | D To issuer deriv | 2026-07-15 | 2026-07-17 | 21,416 | — | $0 | 0 | SEC↗ |
| Kalb Michael Wayne | Chief Financial Officer | D To issuer deriv | 2026-07-15 | 2026-07-17 | 131,536 | — | $0 | 0 | SEC↗ |
| Kalb Michael Wayne | Chief Financial Officer | D To issuer deriv | 2026-07-15 | 2026-07-17 | 169,248 | — | $0 | 0 | SEC↗ |
| Kalb Michael Wayne | Chief Financial Officer | D To issuer deriv | 2026-07-15 | 2026-07-17 | 257,214 | — | $0 | 0 | SEC↗ |
| DENKHAUS DONALD A | Director | D To issuer deriv | 2026-07-15 | 2026-07-17 | 20,000 | — | $0 | 0 | SEC↗ |
| DENKHAUS DONALD A | Director | D To issuer deriv | 2026-07-15 | 2026-07-17 | 30,000 | — | $0 | 0 | SEC↗ |
| DENKHAUS DONALD A | Director | D To issuer deriv | 2026-07-15 | 2026-07-17 | 33,500 | — | $0 | 0 | SEC↗ |
| Miller Steve | Chief Op. & Scientific Offic | D To issuer deriv | 2026-07-15 | 2026-07-17 | 47,826 | — | $0 | 0 | SEC↗ |
| Miller Steve | Chief Op. & Scientific Offic | D To issuer deriv | 2026-07-15 | 2026-07-17 | 16,534 | — | $0 | 0 | SEC↗ |
| Miller Steve | Chief Op. & Scientific Offic | D To issuer deriv | 2026-07-15 | 2026-07-17 | 11,873 | — | $0 | 0 | SEC↗ |
| Miller Steve | Chief Op. & Scientific Offic | D To issuer deriv | 2026-07-15 | 2026-07-17 | 158,454 | — | $0 | 0 | SEC↗ |
| Miller Steve | Chief Op. & Scientific Offic | D To issuer deriv | 2026-07-15 | 2026-07-17 | 202,958 | — | $0 | 0 | SEC↗ |
| Miller Steve | Chief Op. & Scientific Offic | D To issuer deriv | 2026-07-15 | 2026-07-17 | 248,004 | — | $0 | 0 | SEC↗ |
| Miller Steve | Chief Op. & Scientific Offic | D To issuer deriv | 2026-07-15 | 2026-07-17 | 146,000 | — | $0 | 0 | SEC↗ |
| Miller Steve | Chief Op. & Scientific Offic | D To issuer deriv | 2026-07-15 | 2026-07-17 | 185,000 | — | $0 | 0 | SEC↗ |
| Miller Steve | Chief Op. & Scientific Offic | D To issuer deriv | 2026-07-15 | 2026-07-17 | 275,000 | — | $0 | 0 | SEC↗ |
| Miller Steve | Chief Op. & Scientific Offic | D To issuer deriv | 2026-07-15 | 2026-07-17 | 180,000 | — | $0 | 0 | SEC↗ |
| Russo Gregg | Chief HR Officer | D To issuer deriv | 2026-07-15 | 2026-07-17 | 6,197 | — | $0 | 0 | SEC↗ |
| Russo Gregg | Chief HR Officer | D To issuer deriv | 2026-07-15 | 2026-07-17 | 2,752 | — | $0 | 0 | SEC↗ |
| Russo Gregg | Chief HR Officer | D To issuer deriv | 2026-07-15 | 2026-07-17 | 20,531 | — | $0 | 0 | SEC↗ |
| Russo Gregg | Chief HR Officer | D To issuer deriv | 2026-07-15 | 2026-07-17 | 20,349 | — | $0 | 0 | SEC↗ |
| Russo Gregg | Chief HR Officer | D To issuer deriv | 2026-07-15 | 2026-07-17 | 6,957 | — | $0 | 0 | SEC↗ |
| Russo Gregg | Chief HR Officer | D To issuer deriv | 2026-07-15 | 2026-07-17 | 15,000 | — | $0 | 0 | SEC↗ |
| Tierney David S | Director | D To issuer deriv | 2026-07-15 | 2026-07-17 | 30,000 | — | $0 | 0 | SEC↗ |
| Tierney David S | Director | D To issuer deriv | 2026-07-15 | 2026-07-17 | 33,500 | — | $0 | 0 | SEC↗ |
| Daly Richard J | President and CEO | D To issuer deriv | 2026-07-15 | 2026-07-17 | 115,283 | — | $0 | 0 | SEC↗ |
| Daly Richard J | President and CEO | D To issuer deriv | 2026-07-15 | 2026-07-17 | 40,013 | — | $0 | 0 | SEC↗ |
| Daly Richard J | President and CEO | D To issuer deriv | 2026-07-15 | 2026-07-17 | 126,316 | — | $0 | 0 | SEC↗ |
| Daly Richard J | President and CEO | D To issuer deriv | 2026-07-15 | 2026-07-17 | 381,948 | — | $0 | 0 | SEC↗ |
| Daly Richard J | President and CEO | D To issuer deriv | 2026-07-15 | 2026-07-17 | 491,160 | — | $0 | 0 | SEC↗ |
| Daly Richard J | President and CEO | D To issuer deriv | 2026-07-15 | 2026-07-17 | 1,365,319 | — | $0 | 0 | SEC↗ |
| Daly Richard J | President and CEO | D To issuer deriv | 2026-07-15 | 2026-07-17 | 15,000 | — | $0 | 0 | SEC↗ |
| Daly Richard J | President and CEO | D To issuer deriv | 2026-07-15 | 2026-07-17 | 20,000 | — | $0 | 0 | SEC↗ |
| Daly Richard J | President and CEO | D To issuer deriv | 2026-07-15 | 2026-07-17 | 30,000 | — | $0 | 0 | SEC↗ |
| Daly Richard J | President and CEO | D To issuer deriv | 2026-07-15 | 2026-07-17 | 33,500 | — | $0 | 0 | SEC↗ |
| Curran Daniel J. | Director | D To issuer deriv | 2026-07-15 | 2026-07-17 | 5,468 | — | $0 | 0 | SEC↗ |
| Curran Daniel J. | Director | D To issuer deriv | 2026-07-15 | 2026-07-17 | 18,115 | — | $0 | 0 | SEC↗ |
| Sundaram Preethi | Chief Strategy Officer | D To issuer deriv | 2026-07-15 | 2026-07-17 | 32,257 | — | $0 | 0 | SEC↗ |
| Sundaram Preethi | Chief Strategy Officer | D To issuer deriv | 2026-07-15 | 2026-07-17 | 11,206 | — | $0 | 0 | SEC↗ |
| Sundaram Preethi | Chief Strategy Officer | D To issuer deriv | 2026-07-15 | 2026-07-17 | 6,855 | — | $0 | 0 | SEC↗ |
| Sundaram Preethi | Chief Strategy Officer | D To issuer deriv | 2026-07-15 | 2026-07-17 | 106,873 | — | $0 | 0 | SEC↗ |
| Sundaram Preethi | Chief Strategy Officer | D To issuer deriv | 2026-07-15 | 2026-07-17 | 137,553 | — | $0 | 0 | SEC↗ |
| Sundaram Preethi | Chief Strategy Officer | D To issuer deriv | 2026-07-15 | 2026-07-17 | 143,193 | — | $0 | 0 | SEC↗ |
| Sundaram Preethi | Chief Strategy Officer | D To issuer deriv | 2026-07-15 | 2026-07-17 | 68,000 | — | $0 | 0 | SEC↗ |
| Sundaram Preethi | Chief Strategy Officer | D To issuer deriv | 2026-07-15 | 2026-07-17 | 67,500 | — | $0 | 0 | SEC↗ |
| Tierney David S | Director | D To issuer deriv | 2026-07-15 | 2026-07-17 | 5,468 | — | $0 | 0 | SEC↗ |
| Tierney David S | Director | D To issuer deriv | 2026-07-15 | 2026-07-17 | 1,894 | — | $0 | 0 | SEC↗ |
| Tierney David S | Director | D To issuer deriv | 2026-07-15 | 2026-07-17 | 1,414 | — | $0 | 0 | SEC↗ |
| Tierney David S | Director | D To issuer deriv | 2026-07-15 | 2026-07-17 | 18,115 | — | $0 | 0 | SEC↗ |
| Tierney David S | Director | D To issuer deriv | 2026-07-15 | 2026-07-17 | 23,248 | — | $0 | 0 | SEC↗ |
| Tierney David S | Director | D To issuer deriv | 2026-07-15 | 2026-07-17 | 29,524 | — | $0 | 0 | SEC↗ |
| Tierney David S | Director | D To issuer deriv | 2026-07-15 | 2026-07-17 | 15,000 | — | $0 | 0 | SEC↗ |
| Tierney David S | Director | D To issuer deriv | 2026-07-15 | 2026-07-17 | 20,000 | — | $0 | 0 | SEC↗ |
| Del Carmen Jeffrey | Chief Commercial Officer | D To issuer deriv | 2026-07-15 | 2026-07-17 | 32,257 | — | $0 | 0 | SEC↗ |
| Del Carmen Jeffrey | Chief Commercial Officer | D To issuer deriv | 2026-07-15 | 2026-07-17 | 11,206 | — | $0 | 0 | SEC↗ |
| Del Carmen Jeffrey | Chief Commercial Officer | D To issuer deriv | 2026-07-15 | 2026-07-17 | 8,039 | — | $0 | 0 | SEC↗ |
| Del Carmen Jeffrey | Chief Commercial Officer | D To issuer deriv | 2026-07-15 | 2026-07-17 | 106,873 | — | $0 | 0 | SEC↗ |
| Del Carmen Jeffrey | Chief Commercial Officer | D To issuer deriv | 2026-07-15 | 2026-07-17 | 137,553 | — | $0 | 0 | SEC↗ |
| Del Carmen Jeffrey | Chief Commercial Officer | D To issuer deriv | 2026-07-15 | 2026-07-17 | 167,918 | — | $0 | 0 | SEC↗ |
| Del Carmen Jeffrey | Chief Commercial Officer | D To issuer deriv | 2026-07-15 | 2026-07-17 | 88,000 | — | $0 | 0 | SEC↗ |
| Del Carmen Jeffrey | Chief Commercial Officer | D To issuer deriv | 2026-07-15 | 2026-07-17 | 135,000 | — | $0 | 0 | SEC↗ |
| Del Carmen Jeffrey | Chief Commercial Officer | D To issuer deriv | 2026-07-15 | 2026-07-17 | 200,000 | — | $0 | 0 | SEC↗ |
| Del Carmen Jeffrey | Chief Commercial Officer | D To issuer deriv | 2026-07-15 | 2026-07-17 | 150,000 | — | $0 | 0 | SEC↗ |
| MCENANY PATRICK J | Director | D To issuer deriv | 2026-07-15 | 2026-07-17 | 10,540 | — | $0 | 0 | SEC↗ |
| MCENANY PATRICK J | Director | D To issuer deriv | 2026-07-15 | 2026-07-17 | 3,552 | — | $0 | 0 | SEC↗ |
| Harper Molly | Director | D To issuer deriv | 2026-07-15 | 2026-07-17 | 5,468 | — | $0 | 0 | SEC↗ |
| Harper Molly | Director | D To issuer deriv | 2026-07-15 | 2026-07-17 | 1,894 | — | $0 | 0 | SEC↗ |
| Harper Molly | Director | D To issuer deriv | 2026-07-15 | 2026-07-17 | 1,414 | — | $0 | 0 | SEC↗ |
| Harper Molly | Director | D To issuer deriv | 2026-07-15 | 2026-07-17 | 18,115 | — | $0 | 0 | SEC↗ |
| Harper Molly | Director | D To issuer deriv | 2026-07-15 | 2026-07-17 | 23,248 | — | $0 | 0 | SEC↗ |
| Harper Molly | Director | D To issuer deriv | 2026-07-15 | 2026-07-17 | 29,524 | — | $0 | 0 | SEC↗ |
| Harper Molly | Director | D To issuer deriv | 2026-07-15 | 2026-07-17 | 15,000 | — | $0 | 0 | SEC↗ |
| Harper Molly | Director | D To issuer deriv | 2026-07-15 | 2026-07-17 | 20,000 | — | $0 | 0 | SEC↗ |
| Harper Molly | Director | D To issuer deriv | 2026-07-15 | 2026-07-17 | 12,500 | — | $0 | 0 | SEC↗ |
| Thompson Tamar | Director | D To issuer deriv | 2026-07-15 | 2026-07-17 | 5,468 | — | $0 | 0 | SEC↗ |
| Thompson Tamar | Director | D To issuer deriv | 2026-07-15 | 2026-07-17 | 1,894 | — | $0 | 0 | SEC↗ |
| Thompson Tamar | Director | D To issuer deriv | 2026-07-15 | 2026-07-17 | 1,414 | — | $0 | 0 | SEC↗ |
| Thompson Tamar | Director | D To issuer deriv | 2026-07-15 | 2026-07-17 | 18,115 | — | $0 | 0 | SEC↗ |
| Thompson Tamar | Director | D To issuer deriv | 2026-07-15 | 2026-07-17 | 23,248 | — | $0 | 0 | SEC↗ |
| Thompson Tamar | Director | D To issuer deriv | 2026-07-15 | 2026-07-17 | 29,524 | — | $0 | 0 | SEC↗ |
| Thompson Tamar | Director | D To issuer deriv | 2026-07-15 | 2026-07-17 | 40,000 | — | $0 | 0 | SEC↗ |
| Andrews William T. | Chief Medical Officer | D To issuer deriv | 2026-07-15 | 2026-07-17 | 29,776 | — | $0 | 0 | SEC↗ |
| Andrews William T. | Chief Medical Officer | D To issuer deriv | 2026-07-15 | 2026-07-17 | 12,209 | — | $0 | 0 | SEC↗ |
| Andrews William T. | Chief Medical Officer | D To issuer deriv | 2026-07-15 | 2026-07-17 | 98,652 | — | $0 | 0 | SEC↗ |
| Andrews William T. | Chief Medical Officer | D To issuer deriv | 2026-07-15 | 2026-07-17 | 124,447 | — | $0 | 0 | SEC↗ |
| MCENANY PATRICK J | Director | D To issuer deriv | 2026-07-15 | 2026-07-17 | 3,534 | — | $0 | 0 | SEC↗ |
| MCENANY PATRICK J | Director | D To issuer deriv | 2026-07-15 | 2026-07-17 | 34,921 | — | $0 | 0 | SEC↗ |
| MCENANY PATRICK J | Director | D To issuer deriv | 2026-07-15 | 2026-07-17 | 43,591 | — | $0 | 0 | SEC↗ |
| MCENANY PATRICK J | Director | D To issuer deriv | 2026-07-15 | 2026-07-17 | 73,810 | — | $0 | 0 | SEC↗ |
| MCENANY PATRICK J | Director | D To issuer deriv | 2026-07-15 | 2026-07-17 | 272,000 | — | $0 | 0 | SEC↗ |
| MCENANY PATRICK J | Director | D To issuer deriv | 2026-07-15 | 2026-07-17 | 270,000 | — | $0 | 0 | SEC↗ |
| MCENANY PATRICK J | Director | D To issuer deriv | 2026-07-15 | 2026-07-17 | 400,000 | — | $0 | 0 | SEC↗ |
| MCENANY PATRICK J | Director | D To issuer deriv | 2026-07-15 | 2026-07-17 | 740,000 | — | $0 | 0 | SEC↗ |
| Elsbernd Brian | Chief Legal Officer | D To issuer deriv | 2026-07-15 | 2026-07-17 | 29,776 | — | $0 | 0 | SEC↗ |
| Elsbernd Brian | Chief Legal Officer | D To issuer deriv | 2026-07-15 | 2026-07-17 | 10,322 | — | $0 | 0 | SEC↗ |
| Elsbernd Brian | Chief Legal Officer | D To issuer deriv | 2026-07-15 | 2026-07-17 | 7,067 | — | $0 | 0 | SEC↗ |
| Elsbernd Brian | Chief Legal Officer | D To issuer deriv | 2026-07-15 | 2026-07-17 | 98,652 | — | $0 | 0 | SEC↗ |
| Elsbernd Brian | Chief Legal Officer | D To issuer deriv | 2026-07-15 | 2026-07-17 | 126,704 | — | $0 | 0 | SEC↗ |
| Elsbernd Brian | Chief Legal Officer | D To issuer deriv | 2026-07-15 | 2026-07-17 | 147,621 | — | $0 | 0 | SEC↗ |
| Elsbernd Brian | Chief Legal Officer | D To issuer deriv | 2026-07-15 | 2026-07-17 | 69,000 | — | $0 | 0 | SEC↗ |
| Elsbernd Brian | Chief Legal Officer | D To issuer deriv | 2026-07-15 | 2026-07-17 | 135,000 | — | $0 | 0 | SEC↗ |
| Elsbernd Brian | Chief Legal Officer | D To issuer deriv | 2026-07-15 | 2026-07-17 | 200,000 | — | $0 | 0 | SEC↗ |
| Elsbernd Brian | Chief Legal Officer | D To issuer deriv | 2026-07-15 | 2026-07-17 | 132,000 | — | $0 | 0 | SEC↗ |
| Sundaram Preethi | Chief Strategy Officer | D To issuer deriv | 2026-07-15 | 2026-07-17 | 225,000 | — | $0 | 0 | SEC↗ |
| DENKHAUS DONALD A | Director | D To issuer deriv | 2026-07-15 | 2026-07-17 | 5,468 | — | $0 | 0 | SEC↗ |
| DENKHAUS DONALD A | Director | D To issuer deriv | 2026-07-15 | 2026-07-17 | 1,894 | — | $0 | 0 | SEC↗ |
| DENKHAUS DONALD A | Director | D To issuer deriv | 2026-07-15 | 2026-07-17 | 1,414 | — | $0 | 0 | SEC↗ |
| DENKHAUS DONALD A | Director | D To issuer deriv | 2026-07-15 | 2026-07-17 | 18,115 | — | $0 | 0 | SEC↗ |
| Andrews William T. | Chief Medical Officer | D To issuer | 2026-07-15 | 2026-07-17 | 2,309 | $31.50 | $72.7K | 0 | SEC↗ |
| Thompson Tamar | Director | D To issuer | 2026-07-15 | 2026-07-17 | 3,773 | $31.50 | $118.8K | 0 | SEC↗ |
| Elsbernd Brian | Chief Legal Officer | D To issuer | 2026-07-15 | 2026-07-17 | 242,501 | $31.50 | $7.64M | 0 | SEC↗ |
| Miller Steve | Chief Op. & Scientific Offic | D To issuer | 2026-07-15 | 2026-07-17 | 1,093,803 | $31.50 | $34.45M | 0 | SEC↗ |
| Tierney David S | Director | D To issuer | 2026-07-15 | 2026-07-17 | 383,314 | $31.50 | $12.07M | 0 | SEC↗ |
| Harper Molly | Director | D To issuer | 2026-07-15 | 2026-07-17 | 3,694 | $31.50 | $116.4K | 0 | SEC↗ |
| Sundaram Preethi | Chief Strategy Officer | D To issuer | 2026-07-15 | 2026-07-17 | 54,804 | $31.50 | $1.73M | 0 | SEC↗ |
| Kalb Michael Wayne | Chief Financial Officer | D To issuer | 2026-07-15 | 2026-07-17 | 13,665 | $31.50 | $430.4K | 0 | SEC↗ |
| DENKHAUS DONALD A | Director | D To issuer | 2026-07-15 | 2026-07-17 | 498,773 | $31.50 | $15.71M | 0 | SEC↗ |
| Daly Richard J | President and CEO | D To issuer | 2026-07-15 | 2026-07-17 | 271,266 | $31.50 | $8.54M | 0 | SEC↗ |
| Russo Gregg | Chief HR Officer | D To issuer | 2026-07-15 | 2026-07-17 | 476 | $31.50 | $15.0K | 0 | SEC↗ |
| Del Carmen Jeffrey | Chief Commercial Officer | D To issuer | 2026-07-15 | 2026-07-17 | 14,337 | $31.50 | $451.6K | 0 | SEC↗ |
| MCENANY PATRICK J | Director | D To issuer | 2026-07-15 | 2026-07-17 | 4,171,559 | $31.50 | $131.40M | 0 | SEC↗ |
| Andrews William T. | Chief Medical Officer | F Tax w/h | 2026-06-03 | 2026-06-05 | 743 | — | $0 | 2,309 | SEC↗ |
| Andrews William T. | Chief Medical Officer | M Exercise | 2026-06-03 | 2026-06-05 | 3,052 | — | $0 | 3,052 | SEC↗ |
| Russo Gregg | Chief HR Officer | M Exercise deriv | 2026-02-17 | 2026-02-19 | 687 | — | $0 | 71,786 | SEC↗ |
| Russo Gregg | Chief HR Officer | F Tax w/h | 2026-02-17 | 2026-02-19 | 211 | — | $0 | 476 | SEC↗ |
| Russo Gregg | Chief HR Officer | M Exercise | 2026-02-17 | 2026-02-19 | 687 | — | $0 | 687 | SEC↗ |
| Daly Richard J | President and CEO | M Exercise deriv | 2026-01-05 | 2026-01-06 | 42,105 | — | $0 | 2,618,539 | SEC↗ |
| Kalb Michael Wayne | Executive Vice President & C | M Exercise deriv | 2026-01-05 | 2026-01-06 | 7,139 | — | $0 | 632,903 | SEC↗ |
| Daly Richard J | President and CEO | F Tax w/h | 2026-01-05 | 2026-01-06 | 10,577 | — | $0 | 271,266 | SEC↗ |
| Daly Richard J | President and CEO | M Exercise | 2026-01-05 | 2026-01-06 | 42,105 | — | $0 | 281,843 | SEC↗ |
| Kalb Michael Wayne | Executive Vice President & C | F Tax w/h | 2026-01-05 | 2026-01-06 | 2,080 | — | $0 | 13,665 | SEC↗ |
| Kalb Michael Wayne | Executive Vice President & C | M Exercise | 2026-01-05 | 2026-01-06 | 7,139 | — | $0 | 15,745 | SEC↗ |
| Sundaram Preethi | Chief Strategy Officer | M Exercise deriv | 2025-12-29 | 2025-12-30 | 6,667 | — | $0 | 798,437 | SEC↗ |
| Elsbernd Brian | Chief Compliance/Legal Offic | M Exercise deriv | 2025-12-29 | 2025-12-30 | 6,667 | — | $0 | 956,142 | SEC↗ |
| Tierney David S | Director | M Exercise deriv | 2025-12-29 | 2025-12-30 | 1,334 | — | $0 | 178,163 | SEC↗ |
| Harper Molly | Director | M Exercise deriv | 2025-12-29 | 2025-12-30 | 1,334 | — | $0 | 127,163 | SEC↗ |
| Daly Richard J | President and CEO | M Exercise deriv | 2025-12-29 | 2025-12-30 | 1,334 | — | $0 | 2,660,644 | SEC↗ |
| DENKHAUS DONALD A | Director | M Exercise deriv | 2025-12-29 | 2025-12-30 | 1,334 | — | $0 | 178,163 | SEC↗ |
| Miller Steve | Chief Op. & Scientific Offic | M Exercise deriv | 2025-12-29 | 2025-12-30 | 14,000 | — | $0 | 1,471,649 | SEC↗ |
| Del Carmen Jeffrey | Chief Commercial Officer | M Exercise deriv | 2025-12-29 | 2025-12-30 | 8,667 | — | $0 | 1,036,846 | SEC↗ |
| MCENANY PATRICK J | Director | M Exercise deriv | 2025-12-29 | 2025-12-30 | 26,334 | — | $0 | 1,851,948 | SEC↗ |
| MCENANY PATRICK J | Director | F Tax w/h | 2025-12-29 | 2025-12-30 | 6,786 | — | $0 | 4,171,559 | SEC↗ |
| MCENANY PATRICK J | Director | M Exercise | 2025-12-29 | 2025-12-30 | 26,334 | — | $0 | 4,178,345 | SEC↗ |
| Elsbernd Brian | Chief Compliance/Legal Offic | M Exercise | 2025-12-29 | 2025-12-30 | 6,667 | — | $0 | 245,124 | SEC↗ |
| Elsbernd Brian | Chief Compliance/Legal Offic | F Tax w/h | 2025-12-29 | 2025-12-30 | 2,623 | — | $0 | 242,501 | SEC↗ |
| DENKHAUS DONALD A | Director | M Exercise | 2025-12-29 | 2025-12-30 | 1,334 | — | $0 | 498,773 | SEC↗ |
| Sundaram Preethi | Chief Strategy Officer | F Tax w/h | 2025-12-29 | 2025-12-30 | 2,369 | — | $0 | 54,804 | SEC↗ |
| Sundaram Preethi | Chief Strategy Officer | M Exercise | 2025-12-29 | 2025-12-30 | 6,667 | — | $0 | 57,173 | SEC↗ |
| Del Carmen Jeffrey | Chief Commercial Officer | F Tax w/h | 2025-12-29 | 2025-12-30 | 3,839 | — | $0 | 14,337 | SEC↗ |
| Del Carmen Jeffrey | Chief Commercial Officer | M Exercise | 2025-12-29 | 2025-12-30 | 8,667 | — | $0 | 18,176 | SEC↗ |
| Harper Molly | Director | M Exercise | 2025-12-29 | 2025-12-30 | 1,334 | — | $0 | 3,694 | SEC↗ |
| Tierney David S | Director | M Exercise | 2025-12-29 | 2025-12-30 | 1,334 | — | $0 | 383,314 | SEC↗ |
| Daly Richard J | President and CEO | F Tax w/h | 2025-12-29 | 2025-12-30 | 524 | — | $0 | 239,738 | SEC↗ |
| Daly Richard J | President and CEO | M Exercise | 2025-12-29 | 2025-12-30 | 1,334 | — | $0 | 240,262 | SEC↗ |
| Miller Steve | Chief Op. & Scientific Offic | M Exercise | 2025-12-29 | 2025-12-30 | 14,000 | — | $0 | 1,093,803 | SEC↗ |
| Harper Molly | Director | M Exercise deriv | 2025-12-12 | 2025-12-16 | 20,000 | — | $0 | 128,497 | SEC↗ |
| Harper Molly | Director | S Sale | 2025-12-12 | 2025-12-16 | 6,746 | $23.06 | $155.6K | 2,360 | SEC↗ |
| Harper Molly | Director | M Exercise | 2025-12-12 | 2025-12-16 | 20,000 | $5.78 | $115.6K | 29,106 | SEC↗ |
| Harper Molly | Director | S Sale | 2025-12-12 | 2025-12-16 | 15,527 | $23.20 | $360.2K | 13,579 | SEC↗ |
| Harper Molly | Director | S Sale | 2025-12-12 | 2025-12-16 | 4,473 | $23.73 | $106.1K | 9,106 | SEC↗ |
| Sundaram Preethi | Chief Strategy Officer | M Exercise deriv | 2025-12-08 | 2025-12-10 | 6,855 | — | $0 | 805,104 | SEC↗ |
| Elsbernd Brian | Chief Compliance/Legal Offic | M Exercise deriv | 2025-12-08 | 2025-12-10 | 7,067 | — | $0 | 962,809 | SEC↗ |
| MCENANY PATRICK J | Director | M Exercise deriv | 2025-12-08 | 2025-12-10 | 3,534 | — | $0 | 1,878,282 | SEC↗ |
| Thompson Tamar | Director | M Exercise deriv | 2025-12-08 | 2025-12-10 | 1,413 | — | $0 | 119,663 | SEC↗ |
| Miller Steve | Chief Op. & Scientific Offic | M Exercise deriv | 2025-12-08 | 2025-12-10 | 11,873 | — | $0 | 1,485,649 | SEC↗ |
| Tierney David S | Director | M Exercise deriv | 2025-12-08 | 2025-12-10 | 1,413 | — | $0 | 179,497 | SEC↗ |
| Harper Molly | Director | M Exercise deriv | 2025-12-08 | 2025-12-10 | 1,413 | — | $0 | 148,497 | SEC↗ |
| DENKHAUS DONALD A | Director | M Exercise deriv | 2025-12-08 | 2025-12-10 | 1,413 | — | $0 | 179,497 | SEC↗ |
| Del Carmen Jeffrey | Chief Commercial Officer | M Exercise deriv | 2025-12-08 | 2025-12-10 | 8,039 | — | $0 | 1,045,513 | SEC↗ |
| Tierney David S | Director | M Exercise | 2025-12-08 | 2025-12-10 | 1,413 | — | $0 | 381,980 | SEC↗ |
| Sundaram Preethi | Chief Strategy Officer | M Exercise | 2025-12-08 | 2025-12-10 | 6,855 | — | $0 | 52,175 | SEC↗ |
| Sundaram Preethi | Chief Strategy Officer | F Tax w/h | 2025-12-08 | 2025-12-10 | 1,669 | — | $0 | 50,506 | SEC↗ |
| Miller Steve | Chief Op. & Scientific Offic | M Exercise | 2025-12-08 | 2025-12-10 | 11,873 | — | $0 | 1,079,803 | SEC↗ |
| Thompson Tamar | Director | M Exercise | 2025-12-08 | 2025-12-10 | 1,413 | — | $0 | 3,773 | SEC↗ |
| DENKHAUS DONALD A | Director | M Exercise | 2025-12-08 | 2025-12-10 | 1,413 | — | $0 | 497,439 | SEC↗ |
| Harper Molly | Director | M Exercise | 2025-12-08 | 2025-12-10 | 1,413 | — | $0 | 9,106 | SEC↗ |
| Del Carmen Jeffrey | Chief Commercial Officer | M Exercise | 2025-12-08 | 2025-12-10 | 8,039 | — | $0 | 12,001 | SEC↗ |
| Del Carmen Jeffrey | Chief Commercial Officer | F Tax w/h | 2025-12-08 | 2025-12-10 | 2,492 | — | $0 | 9,509 | SEC↗ |
| Elsbernd Brian | Chief Compliance/Legal Offic | M Exercise | 2025-12-08 | 2025-12-10 | 7,067 | — | $0 | 241,237 | SEC↗ |
| Elsbernd Brian | Chief Compliance/Legal Offic | F Tax w/h | 2025-12-08 | 2025-12-10 | 2,780 | — | $0 | 238,457 | SEC↗ |
| MCENANY PATRICK J | Director | M Exercise | 2025-12-08 | 2025-12-10 | 3,534 | — | $0 | 4,152,011 | SEC↗ |
| MCENANY PATRICK J | Director | G Gift | 2025-12-01 | 2025-12-03 | 45,000 | — | $0 | 4,328,477 | SEC↗ |
| MCENANY PATRICK J | Director | G Gift | 2025-12-01 | 2025-12-03 | 45,000 | — | $0 | 4,193,477 | SEC↗ |
| MCENANY PATRICK J | Director | G Gift | 2025-12-01 | 2025-12-03 | 45,000 | — | $0 | 4,148,477 | SEC↗ |
| Del Carmen Jeffrey | Chief Commercial Officer | M Exercise deriv | 2025-11-26 | 2025-11-28 | 10,983 | — | $0 | 1,053,552 | SEC↗ |
| Del Carmen Jeffrey | Chief Commercial Officer | M Exercise | 2025-11-26 | 2025-11-28 | 10,983 | $4.21 | $46.2K | 14,945 | SEC↗ |
| Del Carmen Jeffrey | Chief Commercial Officer | S Sale | 2025-11-26 | 2025-11-28 | 10,983 | $23.33 | $256.2K | 3,962 | SEC↗ |
| Kalb Michael Wayne | Executive Vice President & C | M Exercise deriv | 2025-11-21 | 2025-11-24 | 6,894 | — | $0 | 640,042 | SEC↗ |
| Tierney David S | Director | M Exercise deriv | 2025-11-21 | 2025-11-24 | 947 | — | $0 | 180,910 | SEC↗ |
| Harper Molly | Director | M Exercise deriv | 2025-11-21 | 2025-11-24 | 947 | — | $0 | 149,910 | SEC↗ |
| Elsbernd Brian | Chief Compliance/Legal Offic | M Exercise deriv | 2025-11-21 | 2025-11-24 | 5,161 | — | $0 | 969,876 | SEC↗ |
| Miller Steve | Chief Op. & Scientific Offic | M Exercise deriv | 2025-11-21 | 2025-11-24 | 8,267 | — | $0 | 1,497,522 | SEC↗ |
| DENKHAUS DONALD A | Director | M Exercise deriv | 2025-11-21 | 2025-11-24 | 947 | — | $0 | 180,910 | SEC↗ |
| Sundaram Preethi | Chief Strategy Officer | M Exercise deriv | 2025-11-21 | 2025-11-24 | 5,603 | — | $0 | 811,959 | SEC↗ |
| Daly Richard J | President and CEO | M Exercise deriv | 2025-11-21 | 2025-11-24 | 20,006 | — | $0 | 2,661,978 | SEC↗ |
| Thompson Tamar | Director | M Exercise deriv | 2025-11-21 | 2025-11-24 | 947 | — | $0 | 121,076 | SEC↗ |
| Del Carmen Jeffrey | Chief Commercial Officer | M Exercise deriv | 2025-11-21 | 2025-11-24 | 5,603 | — | $0 | 1,064,535 | SEC↗ |
| MCENANY PATRICK J | Director | M Exercise deriv | 2025-11-21 | 2025-11-24 | 1,775 | — | $0 | 1,881,816 | SEC↗ |
| Thompson Tamar | Director | M Exercise | 2025-11-21 | 2025-11-24 | 947 | — | $0 | 2,360 | SEC↗ |
| Del Carmen Jeffrey | Chief Commercial Officer | M Exercise | 2025-11-21 | 2025-11-24 | 5,603 | — | $0 | 5,603 | SEC↗ |
| Harper Molly | Director | M Exercise | 2025-11-21 | 2025-11-24 | 947 | — | $0 | 7,693 | SEC↗ |
| Elsbernd Brian | Chief Compliance/Legal Offic | F Tax w/h | 2025-11-21 | 2025-11-24 | 2,030 | — | $0 | 234,170 | SEC↗ |
| Elsbernd Brian | Chief Compliance/Legal Offic | M Exercise | 2025-11-21 | 2025-11-24 | 5,161 | — | $0 | 236,200 | SEC↗ |
| MCENANY PATRICK J | Director | M Exercise | 2025-11-21 | 2025-11-24 | 1,775 | — | $0 | 4,283,477 | SEC↗ |
| Miller Steve | Chief Op. & Scientific Offic | M Exercise | 2025-11-21 | 2025-11-24 | 8,267 | — | $0 | 1,067,930 | SEC↗ |
| Kalb Michael Wayne | Executive Vice President & C | F Tax w/h | 2025-11-21 | 2025-11-24 | 2,485 | — | $0 | 8,606 | SEC↗ |
| Kalb Michael Wayne | Executive Vice President & C | M Exercise | 2025-11-21 | 2025-11-24 | 6,894 | — | $0 | 11,091 | SEC↗ |
| Sundaram Preethi | Chief Strategy Officer | F Tax w/h | 2025-11-21 | 2025-11-24 | 1,364 | — | $0 | 45,320 | SEC↗ |
| Sundaram Preethi | Chief Strategy Officer | M Exercise | 2025-11-21 | 2025-11-24 | 5,603 | — | $0 | 46,684 | SEC↗ |
| DENKHAUS DONALD A | Director | M Exercise | 2025-11-21 | 2025-11-24 | 947 | — | $0 | 496,026 | SEC↗ |
| Daly Richard J | President and CEO | F Tax w/h | 2025-11-21 | 2025-11-24 | 7,872 | — | $0 | 238,928 | SEC↗ |
| Daly Richard J | President and CEO | M Exercise | 2025-11-21 | 2025-11-24 | 20,006 | — | $0 | 246,800 | SEC↗ |
| Del Carmen Jeffrey | Chief Commercial Officer | F Tax w/h | 2025-11-21 | 2025-11-24 | 1,641 | — | $0 | 3,962 | SEC↗ |
| Tierney David S | Director | M Exercise | 2025-11-21 | 2025-11-24 | 947 | — | $0 | 380,567 | SEC↗ |
| Kalb Michael Wayne | Executive Vice President & C | A Award deriv | 2025-11-20 | 2025-11-24 | 39,701 | — | $0 | 646,936 | SEC↗ |
| Kalb Michael Wayne | Executive Vice President & C | A Award deriv | 2025-11-20 | 2025-11-24 | 131,536 | — | $0 | 607,235 | SEC↗ |
| Curran Daniel J. | Director | A Award deriv | 2025-11-20 | 2025-11-24 | 5,468 | — | $0 | 63,583 | SEC↗ |
| Curran Daniel J. | Director | A Award deriv | 2025-11-20 | 2025-11-24 | 18,115 | — | $0 | 58,115 | SEC↗ |
| Tierney David S | Director | A Award deriv | 2025-11-20 | 2025-11-24 | 5,468 | — | $0 | 181,857 | SEC↗ |
| Tierney David S | Director | A Award deriv | 2025-11-20 | 2025-11-24 | 18,115 | — | $0 | 176,389 | SEC↗ |
| Russo Gregg | Chief HR Officer | A Award deriv | 2025-11-20 | 2025-11-24 | 6,197 | — | $0 | 72,473 | SEC↗ |
| Harper Molly | Director | A Award deriv | 2025-11-20 | 2025-11-24 | 5,468 | — | $0 | 150,857 | SEC↗ |
| Harper Molly | Director | A Award deriv | 2025-11-20 | 2025-11-24 | 18,115 | — | $0 | 145,389 | SEC↗ |
| Elsbernd Brian | Chief Compliance/Legal Offic | A Award deriv | 2025-11-20 | 2025-11-24 | 29,776 | — | $0 | 975,037 | SEC↗ |
| Elsbernd Brian | Chief Compliance/Legal Offic | A Award deriv | 2025-11-20 | 2025-11-24 | 98,652 | — | $0 | 945,161 | SEC↗ |
| Andrews William T. | Chief Medical Officer | A Award deriv | 2025-11-20 | 2025-11-24 | 29,776 | — | $0 | 268,136 | SEC↗ |
| Andrews William T. | Chief Medical Officer | A Award deriv | 2025-11-20 | 2025-11-24 | 98,652 | — | $0 | 238,360 | SEC↗ |
| Miller Steve | Chief Op. & Scientific Offic | A Award deriv | 2025-11-20 | 2025-11-24 | 47,826 | — | $0 | 1,489,255 | SEC↗ |
| Miller Steve | Chief Op. & Scientific Offic | A Award deriv | 2025-11-20 | 2025-11-24 | 158,454 | — | $0 | 1,457,963 | SEC↗ |
| DENKHAUS DONALD A | Director | A Award deriv | 2025-11-20 | 2025-11-24 | 5,468 | — | $0 | 181,857 | SEC↗ |
| DENKHAUS DONALD A | Director | A Award deriv | 2025-11-20 | 2025-11-24 | 18,115 | — | $0 | 176,389 | SEC↗ |
| Sundaram Preethi | Chief Strategy Officer | A Award deriv | 2025-11-20 | 2025-11-24 | 32,257 | — | $0 | 817,562 | SEC↗ |
| Sundaram Preethi | Chief Strategy Officer | A Award deriv | 2025-11-20 | 2025-11-24 | 106,873 | — | $0 | 785,305 | SEC↗ |
| Daly Richard J | President and CEO | A Award deriv | 2025-11-20 | 2025-11-24 | 115,283 | — | $0 | 2,681,984 | SEC↗ |
| Daly Richard J | President and CEO | A Award deriv | 2025-11-20 | 2025-11-24 | 381,948 | — | $0 | 2,546,695 | SEC↗ |
| Thompson Tamar | Director | A Award deriv | 2025-11-20 | 2025-11-24 | 5,468 | — | $0 | 122,023 | SEC↗ |
| Thompson Tamar | Director | A Award deriv | 2025-11-20 | 2025-11-24 | 18,115 | — | $0 | 116,555 | SEC↗ |
| Del Carmen Jeffrey | Chief Commercial Officer | A Award deriv | 2025-11-20 | 2025-11-24 | 32,257 | — | $0 | 1,070,138 | SEC↗ |
| Del Carmen Jeffrey | Chief Commercial Officer | A Award deriv | 2025-11-20 | 2025-11-24 | 106,873 | — | $0 | 1,037,881 | SEC↗ |
| MCENANY PATRICK J | Director | A Award deriv | 2025-11-20 | 2025-11-24 | 10,540 | — | $0 | 1,883,591 | SEC↗ |
| MCENANY PATRICK J | Director | A Award deriv | 2025-11-20 | 2025-11-24 | 34,921 | — | $0 | 1,873,051 | SEC↗ |
| Russo Gregg | Chief HR Officer | A Award deriv | 2025-11-20 | 2025-11-24 | 20,531 | — | $0 | 66,276 | SEC↗ |
| Elsbernd Brian | Chief Compliance/Legal Offic | S Sale | 2025-11-12 | 2025-11-14 | 40,000 | $22.70 | $908.0K | 231,039 | SEC↗ |
| Elsbernd Brian | Chief Compliance/Legal Offic | M Exercise deriv | 2025-09-08 | 2025-09-10 | 112,475 | — | $0 | 846,609 | SEC↗ |
| Elsbernd Brian | Chief Compliance/Legal Offic | S Sale | 2025-09-08 | 2025-09-10 | 30,000 | $20.30 | $609.0K | 271,039 | SEC↗ |
| Elsbernd Brian | Chief Compliance/Legal Offic | M Exercise | 2025-09-08 | 2025-09-10 | 112,475 | $2.24 | $251.9K | 301,039 | SEC↗ |
| Elsbernd Brian | Chief Compliance/Legal Offic | M Exercise deriv | 2025-09-04 | 2025-09-05 | 30,000 | — | $0 | 959,084 | SEC↗ |
| Elsbernd Brian | Chief Compliance/Legal Offic | M Exercise | 2025-09-04 | 2025-09-05 | 30,000 | $2.24 | $67.2K | 218,564 | SEC↗ |
| Elsbernd Brian | Chief Compliance/Legal Offic | S Sale | 2025-09-04 | 2025-09-05 | 30,000 | $19.52 | $585.6K | 188,564 | SEC↗ |
| Elsbernd Brian | Chief Compliance/Legal Offic | M Exercise deriv | 2025-09-03 | 2025-09-05 | 20,000 | — | $0 | 989,084 | SEC↗ |
| Elsbernd Brian | Chief Compliance/Legal Offic | S Sale | 2025-09-03 | 2025-09-05 | 20,000 | $20.08 | $401.6K | 188,564 | SEC↗ |
| Elsbernd Brian | Chief Compliance/Legal Offic | M Exercise | 2025-09-03 | 2025-09-05 | 20,000 | $2.24 | $44.8K | 208,564 | SEC↗ |
| Miller Steve | Chief Op. & Scientific Offic | M Exercise deriv | 2025-08-27 | 2025-08-28 | 110,000 | — | $0 | 1,299,509 | SEC↗ |
| Tierney David S | Director | M Exercise deriv | 2025-08-27 | 2025-08-28 | 50,000 | — | $0 | 158,274 | SEC↗ |
| Miller Steve | Chief Op. & Scientific Offic | M Exercise | 2025-08-27 | 2025-08-28 | 110,000 | $2.24 | $246.4K | 1,059,663 | SEC↗ |
| Tierney David S | Director | M Exercise | 2025-08-27 | 2025-08-28 | 50,000 | $2.24 | $112.0K | 405,620 | SEC↗ |
| Tierney David S | Director | S Sale | 2025-08-27 | 2025-08-28 | 26,000 | $20.20 | $525.2K | 379,620 | SEC↗ |
| Daly Richard J | President and CEO | M Exercise deriv | 2025-08-26 | 2025-08-28 | 50,000 | — | $0 | 2,184,753 | SEC↗ |
| Miller Steve | Chief Op. & Scientific Offic | M Exercise deriv | 2025-08-26 | 2025-08-28 | 115,000 | — | $0 | 1,409,509 | SEC↗ |
| Daly Richard J | President and CEO | S Sale | 2025-08-26 | 2025-08-28 | 22,970 | $20.62 | $473.6K | 226,794 | SEC↗ |
| Daly Richard J | President and CEO | M Exercise | 2025-08-26 | 2025-08-28 | 50,000 | $2.24 | $112.0K | 249,764 | SEC↗ |
| Miller Steve | Chief Op. & Scientific Offic | S Sale | 2025-08-26 | 2025-08-28 | 115,000 | $20.28 | $2.33M | 949,663 | SEC↗ |
| Miller Steve | Chief Op. & Scientific Offic | M Exercise | 2025-08-26 | 2025-08-28 | 115,000 | $2.24 | $257.6K | 1,064,663 | SEC↗ |
| Sundaram Preethi | Chief Strategy Officer | S Sale | 2025-06-11 | 2025-06-12 | 1,600 | $26.42 | $42.3K | 41,081 | SEC↗ |
| Sundaram Preethi | Chief Strategy Officer | S Sale | 2025-06-10 | 2025-06-12 | 2,324 | $26.41 | $61.4K | 42,681 | SEC↗ |
| MCENANY PATRICK J | Director | S Sale | 2025-06-09 | 2025-06-10 | 171,748 | $26.11 | $4.48M | 4,281,702 | SEC↗ |
| MCENANY PATRICK J | Director | S Sale | 2025-06-06 | 2025-06-10 | 28,252 | $25.95 | $733.1K | 4,453,450 | SEC↗ |
| Andrews William T. | Chief Medical Officer | M Exercise deriv | 2025-06-03 | 2026-06-05 | 3,052 | — | $0 | 240,195 | SEC↗ |
| Daly Richard J | President and CEO | S Sale | 2025-05-30 | 2025-06-03 | 70,000 | $24.86 | $1.74M | 199,764 | SEC↗ |
| INGENITO GARY | Chief Med. & Reg. Officer | M Exercise deriv | 2025-05-14 | 2025-05-15 | 44,000 | — | $0 | 546,282 | SEC↗ |
| INGENITO GARY | Chief Med. & Reg. Officer | S Sale | 2025-05-14 | 2025-05-15 | 44,000 | $23.63 | $1.04M | 68,873 | SEC↗ |
| INGENITO GARY | Chief Med. & Reg. Officer | M Exercise | 2025-05-14 | 2025-05-15 | 44,000 | $4.64 | $204.2K | 112,873 | SEC↗ |
| INGENITO GARY | Chief Med. & Reg. Officer | M Exercise deriv | 2025-05-13 | 2025-05-15 | 200,000 | — | $0 | 590,282 | SEC↗ |
| INGENITO GARY | Chief Med. & Reg. Officer | M Exercise | 2025-05-13 | 2025-05-15 | 200,000 | $3.42 | $684.0K | 268,873 | SEC↗ |
| INGENITO GARY | Chief Med. & Reg. Officer | S Sale | 2025-05-13 | 2025-05-15 | 200,000 | $23.68 | $4.74M | 68,873 | SEC↗ |
| INGENITO GARY | Chief Med. & Reg. Officer | M Exercise deriv | 2025-03-06 | 2025-03-07 | 180,096 | — | $0 | 790,282 | SEC↗ |
| INGENITO GARY | Chief Med. & Reg. Officer | M Exercise | 2025-03-06 | 2025-03-07 | 180,096 | $2.24 | $403.4K | 248,969 | SEC↗ |
| INGENITO GARY | Chief Med. & Reg. Officer | S Sale | 2025-03-06 | 2025-03-07 | 180,096 | $21.67 | $3.90M | 68,873 | SEC↗ |
| INGENITO GARY | Chief Med. & Reg. Officer | M Exercise deriv | 2025-03-05 | 2025-03-07 | 44,904 | — | $0 | 970,378 | SEC↗ |
| INGENITO GARY | Chief Med. & Reg. Officer | M Exercise | 2025-03-05 | 2025-03-07 | 44,904 | $2.24 | $100.6K | 113,777 | SEC↗ |
| INGENITO GARY | Chief Med. & Reg. Officer | S Sale | 2025-03-05 | 2025-03-07 | 44,904 | $22.09 | $991.9K | 68,873 | SEC↗ |
| Elsbernd Brian | Chief Compliance/Legal Offic | M Exercise deriv | 2025-03-03 | 2025-03-05 | 9,270 | — | $0 | 1,062,339 | SEC↗ |
| Elsbernd Brian | Chief Compliance/Legal Offic | M Exercise deriv | 2025-03-03 | 2025-03-05 | 53,255 | — | $0 | 1,009,084 | SEC↗ |
| Del Carmen Jeffrey | Chief Commercial Officer | S Sale | 2025-03-03 | 2025-03-05 | 30,423 | $22.89 | $696.4K | 0 | SEC↗ |
| Elsbernd Brian | Chief Compliance/Legal Offic | S Sale | 2025-03-03 | 2025-03-05 | 53,255 | $22.93 | $1.22M | 188,564 | SEC↗ |
| Elsbernd Brian | Chief Compliance/Legal Offic | M Exercise | 2025-03-03 | 2025-03-05 | 53,255 | $2.24 | $119.3K | 241,819 | SEC↗ |
| Elsbernd Brian | Chief Compliance/Legal Offic | S Sale | 2025-03-03 | 2025-03-05 | 9,720 | $23.23 | $225.8K | 188,564 | SEC↗ |
| Elsbernd Brian | Chief Compliance/Legal Offic | M Exercise | 2025-03-03 | 2025-03-05 | 9,270 | $2.24 | $20.8K | 197,834 | SEC↗ |
| Miller Steve | Chief Op. & Scientific Offic | M Exercise deriv | 2025-02-14 | 2025-02-19 | 13,667 | — | $0 | 1,524,509 | SEC↗ |
| INGENITO GARY | Chief Med. & Reg. Officer | M Exercise deriv | 2025-02-14 | 2025-02-19 | 10,000 | — | $0 | 1,015,282 | SEC↗ |
| DENKHAUS DONALD A | Director | M Exercise deriv | 2025-02-14 | 2025-02-19 | 4,000 | — | $0 | 158,274 | SEC↗ |
| O'Keeffe Charles B | Director | M Exercise deriv | 2025-02-14 | 2025-02-19 | 4,000 | — | $0 | 208,274 | SEC↗ |
| Tierney David S | Director | M Exercise deriv | 2025-02-14 | 2025-02-19 | 4,000 | — | $0 | 208,274 | SEC↗ |
| Daly Richard J | President and CEO | M Exercise deriv | 2025-02-14 | 2025-02-19 | 4,000 | — | $0 | 2,234,753 | SEC↗ |